BioClavis
Home News Conferences Customer Page FAQ'S
Enquiries
TempO-Seq TempO-Seq Workflow Resources Publications FAQs Detector Oligo Design Limitations of RNA-seq TempO-Span Patents
Panels TempO-Seq TempO-LINC FFPE TempO-Seq Blood Spot TempO-Seq miRNA TempO-Seq R Data Analysis Assays Collaborations
Pharma Academic research Clinical research Bioinformatics services Customer Page
Our story CSR Careers
Home TECHNOLOGY TempO-Seq TempO-Seq Workflow Resources Publications FAQs Detector Oligo Design Limitations of RNA-seq TempO-Span Patents Products Panels TempO-Seq TempO-LINC FFPE TempO-Seq Blood Spot TempO-Seq miRNA TempO-Seq R Data Analysis Assays Collaborations Services Pharma Academic research Clinical research Bioinformatics services Customer Page NewsConferences About Our story CSR Careers Customer PageFAQ'S
BioClavis
Enabling high-throughput transcriptomics using TempO-Seq
Enquiries

Posters

Capewell, P., Mallon, E., Loane, J. et al. Development of a Prognostic Test for Breast Cancer Recurrence Using a Highly Efficient Molecular Profiling Platform. ESMO Breast Cancer 2022.


« Go back

Hours
Mon 9am - 6pm
Tue 9am - 6pm
Wed 9am - 6pm
Thu 9am - 6pm
Fri 9am - 6pm
BIOCLAVIS, LTD.

Carus House
201 Dumbarton Road
Clydebank, G81 4XJ
+44 (0) 141 286 5100
Contact
 
ABOUT

Our Story
CSR
Careers
TEMPO-SEQ

Overview
Resources
SERVICES

Pharma
Academic research
Clinical research
Sample submission
NEWS

EVENTS